Cargando…

The role of thyroglobulin doubling time in differentiated thyroid cancer: a meta-analysis

OBJECTIVE: In patients with differentiated thyroid cancer (DTC), recurrences may occur in up to 20% and may have a fatal outcome in 10% of cases. Thyroglobulin doubling time (Tg-DT) values may contribute to predict response to treatment and disease recurrence in DTC patients. This study aimed to add...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giovanella, Luca, Garo, Maria Luisa, Albano, Domenico, Görges, Rainer, Ceriani, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066573/ https://www.ncbi.nlm.nih.gov/pubmed/35245206 http://dx.doi.org/10.1530/EC-21-0648

Ejemplares similares

Lymph Node Thyroglobulin Measurement in Diagnosis of Neck Metastases of Differentiated Thyroid Carcinoma
por: Giovanella, Luca, et al.
Publicado: (2011)

Thyroid Hormone Withdrawal versus Recombinant Human TSH as Preparation for I-131 Therapy in Patients with Metastatic Thyroid Cancer: A Systematic Review and Meta-Analysis
por: Giovanella, Luca, et al.
Publicado: (2023)

Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer
por: Giovanella, Luca, et al.
Publicado: (2023)

Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [(18)F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma
por: Albano, Domenico, et al.
Publicado: (2020)

Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients
por: Campennì, Alfredo, et al.
Publicado: (2023)

(99m)Tc-Pertechnetate Scintigraphy Predicts Successful Postoperative Ablation in Differentiated Thyroid Carcinoma Patients Treated with Low Radioiodine Activities
por: Giovanella, Luca, et al.
Publicado: (2019)

Accuracy of papillary thyroid cancer prognostic nomograms: a systematic review
por: Luisa Garo, Maria, et al.
Publicado: (2023)

Prognostic Significance of Thyroglobulin Antibodies in Differentiated Thyroid Cancer
por: Reverter, Jordi L., et al.
Publicado: (2020)

The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Aggressive Histological Subtypes of Thyroid Cancer: An Overview
por: Treglia, Giorgio, et al.
Publicado: (2013)

Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers
por: Campennì, Alfredo, et al.
Publicado: (2022)

DIAGNOSIS OF ENDOCRINE DISEASE: Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper
por: Giovanella, Luca, et al.
Publicado: (2014)

Utility of Stimulated Thyroglobulin in the Differentiate Thyroid Cancer
por: Romero, Fabiola, et al.
Publicado: (2021)

Evaluation of a new automated assay for high-sensitivity thyroglobulin measurement and comparison with two established high-sensitivity thyroglobulin assays()
por: Broecker-Preuss, Martina, et al.
Publicado: (2021)

The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer
por: Szujo, Szabina, et al.
Publicado: (2021)

The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients With Differentiated Thyroid Cancer
por: Li, Sha, et al.
Publicado: (2022)

The Role of Pre-ablative Stimulated Thyroglobulin and Thyroglobulin/ Thyroid-Stimulating Hormone Ratio for Predicting Metastasis in Thyroid Cancer
por: Demir, Fadime, et al.
Publicado: (2019)

Undetectable or low (<1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients
por: Campennì, Alfredo, et al.
Publicado: (2018)

Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma
por: Jiang, Nan, et al.
Publicado: (2023)

Radiomics analysis improves (18)FDG PET/CT-based risk stratification of cytologically indeterminate thyroid nodules
por: Giovanella, Luca, et al.
Publicado: (2021)

Predictive value of highly sensitive basal versus stimulated thyroglobulin measurement in long-term follow-up of thyroid cancer
por: Pabst, Kim Magaly, et al.
Publicado: (2022)

Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis
por: Trimboli, Pierpaolo, et al.
Publicado: (2018)

Diagnosis of sarcoidosis in a patient with differentiated thyroid cancer and sudden rise of anti-thyroglobulin antibodies during follow-up
por: Vanessa, Feudo, et al.
Publicado: (2021)

Radioiodine therapy in differentiated thyroid cancer. There is (still) a great chaos under heaven: is the situation excellent?
por: Giovanella, Luca
Publicado: (2023)

High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma
por: Qin, Jing, et al.
Publicado: (2015)

THYROGLOBULIN AS A TUMOR MARKER IN DIFFERENTIATED THYROID CANCER – CLINICAL CONSIDERATIONS
por: Prpić, Marin, et al.
Publicado: (2018)

INTERSTITIAL IMMUNE COMPLEX THYROIDITIS IN MICE : The Role of Autoantibody to Thyroglobulin
por: Clagett, James A., et al.
Publicado: (1974)

Optimization of serum thyroglobulin measured at different time points for prognostic evaluation in differentiated thyroid carcinoma patients
por: Mutsuddy, Pupree, et al.
Publicado: (2020)

How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies
por: Spencer, Carole, et al.
Publicado: (2014)

Can the basal serum thyroglobulin level be used to predict the recombinant human TSH-stimulated thyroglobulin level in differentiated patients with thyroid cancer?
por: Jeong, Eugene, et al.
Publicado: (2019)

Prognostic Value of Serum Thyroglobulin and Anti-Thyroglobulin Antibody in Thyroid Carcinoma Patients following Thyroidectomy
por: Zahra, Hashem O., et al.
Publicado: (2021)

Is There a Role for Unstimulated Thyroglobulin Velocity in Predicting Recurrence in Papillary Thyroid Carcinoma Patients with Detectable Thyroglobulin after Radioiodine Ablation?
por: Wong, Hilda, et al.
Publicado: (2012)

Spontaneous Slowing and Regressing of Tumor Growth in Childhood/Adolescent Papillary Thyroid Carcinomas Suggested by the Postoperative Thyroglobulin-Doubling Time
por: Kasahara, Toshihiko, et al.
Publicado: (2018)

Detection Rate of (18)F-Labeled PSMA PET/CT in Biochemical Recurrent Prostate Cancer: A Systematic Review and a Meta-Analysis
por: Treglia, Giorgio, et al.
Publicado: (2019)

Thyrotrophin receptors, tumour radioiodine concentration and thyroglobulin secretion in differentiated thyroid cancers.
por: Edmonds, C. J., et al.
Publicado: (1985)

Postoperative Stimulated Thyroglobulin Level and Recurrence Risk Stratification in Differentiated Thyroid Cancer
por: Yang, Xue, et al.
Publicado: (2015)

Preoperative Serum Thyroglobulin and Its Correlation with the Burden and Extent of Differentiated Thyroid Cancer
por: Kim, Hosu, et al.
Publicado: (2020)

Clinical irrelevance of lower titer thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma
por: Dekker, Bernadette L, et al.
Publicado: (2022)

Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative (131)I Administration: A Real Life Study
por: Campennì, Alfredo, et al.
Publicado: (2023)

THE ROLE OF MYCOBACTERIA AND THE EFFECT OF PROTEOLYTIC DEGRADATION OF THYROGLOBULIN ON THE PRODUCTION OF AUTOIMMUNE THYROIDITIS
por: Weigle, W. O., et al.
Publicado: (1969)

Impact of Thyroglobulin and Thyroglobulin Antibody Assay Performance on the Differential Classification of DTC Patients
por: Schoonen, Lise, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q9boqej0ifm0biqg5tpgol1ig5